Skip to content


  • Research article
  • Open Access

An assessment on epitope prediction methods for protozoa genomes

  • 1, 2,
  • 4, 5,
  • 4, 5, 6,
  • 2,
  • 2,
  • 2, 3 and
  • 4, 7Email author
Contributed equally
BMC Bioinformatics201213:309

  • Received: 15 March 2012
  • Accepted: 11 November 2012
  • Published:



Epitope prediction using computational methods represents one of the most promising approaches to vaccine development. Reduction of time, cost, and the availability of completely sequenced genomes are key points and highly motivating regarding the use of reverse vaccinology. Parasites of genus Leishmania are widely spread and they are the etiologic agents of leishmaniasis. Currently, there is no efficient vaccine against this pathogen and the drug treatment is highly toxic. The lack of sufficiently large datasets of experimentally validated parasites epitopes represents a serious limitation, especially for trypanomatids genomes. In this work we highlight the predictive performances of several algorithms that were evaluated through the development of a MySQL database built with the purpose of: a) evaluating individual algorithms prediction performances and their combination for CD8+ T cell epitopes, B-cell epitopes and subcellular localization by means of AUC (Area Under Curve) performance and a threshold dependent method that employs a confusion matrix; b) integrating data from experimentally validated and in silico predicted epitopes; and c) integrating the subcellular localization predictions and experimental data. NetCTL, NetMHC, BepiPred, BCPred12, and AAP12 algorithms were used for in silico epitope prediction and WoLF PSORT, Sigcleave and TargetP for in silico subcellular localization prediction against trypanosomatid genomes.


A database-driven epitope prediction method was developed with built-in functions that were capable of: a) removing experimental data redundancy; b) parsing algorithms predictions and storage experimental validated and predict data; and c) evaluating algorithm performances. Results show that a better performance is achieved when the combined prediction is considered. This is particularly true for B cell epitope predictors, where the combined prediction of AAP12 and BCPred12 reached an AUC value of 0.77. For T CD8+ epitope predictors, the combined prediction of NetCTL and NetMHC reached an AUC value of 0.64. Finally, regarding the subcellular localization prediction, the best performance is achieved when the combined prediction of Sigcleave, TargetP and WoLF PSORT is used.


Our study indicates that the combination of B cells epitope predictors is the best tool for predicting epitopes on protozoan parasites proteins. Regarding subcellular localization, the best result was obtained when the three algorithms predictions were combined. The developed pipeline is available upon request to authors.


  • Major Histocompatibility Complex
  • Subcellular Localization
  • Major Histocompatibility Complex Class
  • Epitope Prediction
  • Subcellular Localization Prediction


Reverse vaccinology uses the genome sequences of viral, bacterial or parasitic pathogens of interest rather than the cells as starting material for the identification of novel antigens, whose activity should be subsequently confirmed by experimental biology approaches[1]. In general, the aim of this approach is the identification of genes potentially encoding pathogenicity factors and secreted or membrane-associated proteins. In this context, specific algorithms suitable for the in silico identification of novel surface-exposed and, thus, antibody accessible proteins mediating a protective immune response are used[2].

Pizza and co-workers in collaboration with The Institute for Genomic Research (TIGR) provided the first example of a successful application of the reverse vaccinology approach[3]. They described that in silico identification of vaccine candidates against Neisseria meningitides serogroup B, which is the major cause of sepsis and meningitis in children and young adults, could be effective, while conventional approaches to obtain a vaccine had failed for decades.

New powerful genomic technologies have increased the number of diseases that can be addressed by vaccination, and have reduced the time of discovery research and vaccine development[1]. Nowadays, it costs US$ 200–400 million to research, develop, manufacture and launch a new vaccine on the global market[4]. With the use of reverse vaccinology, time and cost spent on the search of new vaccine targets are significantly reduced.

Immunoinformatics is an emerging application of bioinformatics techniques that focuses on the structure, function, and interactions of the molecules involved in immunity. One of its main goals is the in silico prediction of immunogenicity at epitope level. Recently developed in silico tools and databases can be used to identify, characterize or predict antigen epitopes recognized by T- and B-lymphocytes, cells that play significant roles in infection and protective immunity[5].

Epitopes are the minimal essential units of information derived from self and nonself proteins that stimulate cellular (T-cell) and humoral (B-cell) immune responses. T-cells recognize T-cell epitopes that are derived from endogenous and exogenous proteins and presented in the cleft of MHC class I or MHC class II molecules at the surface of antigen presenting cells to the T-cell receptor. After the activation of CD8+ T cells or CD4+ T cells, respectively, cellular events, such as citotoxicity and cytokine secretion, will occur. B-cells also recognize epitopes, but generally intact proteins. B-cell epitopes can be linear, contiguous amino acids, or discontinuous amino acids that are brought together in folded proteins. After activation, B-cells differentiate into plasmocytes and start secreting antibodies. B- and T-cell responses are called humoral and cellular adaptive immune responses, respectively, and they inform the immune system that a bacteria, virus, or parasite is present[6].

The subcellular localization of the protein is also important to investigate, as immunogenic proteins have to be in contact with T- and B-cells in order to elicit a protective immune response. In other words, correct subcellular localization is of great significance to the functional analysis of proteins[7]. Therefore, various prediction methods have been developed to predict proteins’ subcellular location in the recent decades[8]. Prediction methods to identify the subcellular location of proteins can be classified into two categories: one is based on the recognition of protein N-terminal sorting signals[9] and the other is based on amino acid composition[10]. The predictors then combine these features with machine-learning techniques to decide which is the most probable location[11, 12].

A large variety of machine-learning techniques are commonly used in bioinformatics, including artificial neural networks (ANNs)[13], hidden Markov models (HMMs)[14] and support vector machines (SVMs)[15]. ANNs and SVMs are ideally suited to recognize non-linear patterns, which are believed to contribute to, for instance, peptide-HLA-I interactions[16]. In an ANN, information is trained and distributed into a computer network with an input layer, hidden layers and an output layer all connected in a given structure through weighted connections[13]. Finally, HMMs are well suited to characterized biological motifs with an inherent structural composition, and have been used in the field of immunology to predict peptide binding to major histocompatibility complex (MHC) class I molecules[17].

The use of database system has been constant in the life of researchers and professionals in several fields. Conceptually, a database should be able to provide an easy access to experimental results and lexical surveys, preventing redundancy and wasteful duplication of research data. A well-designed database should also be able to provide support to researchers, facilitating guided searches for novel correlations in data. On the other hand, a poorly designed database makes the data mining process difficult and the new data integration infeasible for regular users[18] and in this perspective, the rebuilding and redesigning processes are frequent[18, 19].

The current challenge of modern biology is to unravel and understand the complex system of biological organization and to signal in all of its details at a molecular level. An essential part of this process goes through bioinformatics, particularly the use of management systems, and relational databases applied to biological data. Biological data reside in specialized databases that represent different data interpretation stages or different facets of biological phenomena[20]. Also, biological data present a particularity: they are highly complex when compared with data from most of other applications. Thus, definitions of such biological data must be able to represent a complex substructure of data as well as their relationships, and also ensure that no information is lost during the biological data modeling. The data model must be able to represent any level of complexity in any data schema, relationship, or schema substructure and not just in a hierarchical, binary, or tabular data format[21].

The main objective of this present work was to build a database-driven epitope prediction method capable of accurately predicting parasite B- and T-cell epitopes, as well as subcellular localization of parasites proteins (Figure 1). The interface language used was standard SQL (Standard Query Language) and several built-in functions were implemented, but are not limited to, the following: a) parse algorithms predictions and storage of experimental validated and predicted data; and b) evaluation of algorithm performances.
Figure 1
Figure 1

The methodology flowchart used to develop this work. A - Construction of the experimentally tested epitopes database, obtained on the curated Immune Epitope Database and Analysis Resource (IEDB) and on Uniprot. B - Algorithms used to predict B-cell epitopes, MHC-I epitopes, MHC-II epitopes and subcellular location of proteins. C - Parsers developed to extract the results. D - Construction of the relational database to integrate the results. E - Analysis of the results in the framework of AUC and confusion error matrix. PERL, Practical and Extraction Report Language; SQL, Structured Query Language.


MHC-I epitopes prediction

Several approaches that predict peptide binding to MHC molecules have been published[22]. In this study we opt for two currently available algorithms, NetCTL[22] and NetMHC[23]. Our choice for these MHC class I epitope prediction algorithms was made in terms of ISI citation indexes and regarding their availability for download and local machine implementation.

When possible, in order to establish the ideal settings for protozoan epitope prediction, the algorithms parameters were scanned and evaluated in terms of AUC values. In this framework, the NetCTL score threshold parameter was ranged from 0.50 to 0.90. The NetCTL and NetMHC algorithms outputs were parsed and the data of 3,906 in silico predicted epitopes loaded into MySQL database. In order to evaluate the algorithm performances, predicted epitopes [see Additional file1 and Additional file2] were aligned against the consensus experimentally validated dataset for MHC class I epitopes. Figure 2 presents an overview of the benchmark approach undertaken in this study (see Methods Section for more details). In addition, we carried out a combined performance analysis using the best score threshold found for each methodology (Table 1).
Figure 2
Figure 2

Strategy employed to assess the predictors’ performance. The scale bar represents the sequence of a theoretical protein of 120 amino acids. Dark blue rectangles represent one single epitope or a consensus of overlapping epitopes that were experimentally validated according to IEDB (Positive exp.); light blue rectangles represent one single non-immunogenic region or a consensus of overlapping non-immunogenic regions that were experimentally validated according to IEDB (Negative exp.); red rectangles represent the predicted epitopes from evaluated algorithms. For B cell prediction the predicted epitopes were considered true positive if they aligned with minimum coverage of 50% and 100% of identity with a Positive Exp. Region; for CD8+ T cell prediction the predicted epitopes were considered true positive if they aligned with minimum coverage of 87% and 100% of identity with a Positive Exp. region (Prediction 1, Prediction 2, Prediction 3 and Prediction 11). For B cell prediction the predicted epitopes were considered false positive if they aligned with minimum coverage of 50% and 100% of identity with a Negative Exp. Region; for CD8+ T cell prediction the predicted epitopes were considered false positive if they aligned with minimum coverage of 87% and 100% of identity with a Negative Exp. region (Prediction 6, Prediction 7, Prediction 8 and Prediction 13). Predictions were not considered during the analysis if they did not align with the parameters cited above (Prediction 4, Prediction 5, Prediction 9 and Prediction 10) or if they aligned with both Positive exp. and Negative exp. (Prediction 12).

Table 1

Algorithms performance evaluation for B cell epitope prediction and CD8+ T cells epitope prediction


AUC values

CD8+ T cells epitope prediction





NetCTL and NetMHC


B cell epitope prediction







AAP12 and BCPred12


AAP12 and BepiPred


BCPred12 and BepiPred


AAP12, BCPred12 and BepiPred


The AUC performance measure obtained for NetCTL was 0.66 (for a score threshold of 0.50) and for NetMHC was 0.60 (score thresholds cannot be modified by the user). On the other hand, the combined performance of these algorithms produced an AUC value of 0.64 (Table 1, Figure 3).
Figure 3
Figure 3

ROC (Received Operating Characteristics) curve representing the performance of CD8+ T cells epitope predictors analyzed (NetCTL and NetMHC), from protozoan proteins database, and their combination. In addition, the black and grey curves represent the performance of the same algorithms for human proteins database (SYFPEITHI) extracted from NetCTL homepage (

B-cell epitopes prediction

Following the same rational described above for MHC I algorithm selection, three currently available algorithms were chosen, BepiPred[24], BCPred12[25] and AAP12[26]. When possible, in order to establish the ideal settings for protozoan epitope prediction, the algorithms parameters were scanned and then evaluated in terms of AUC values. In this framework, the score thresholds parameter ranged from 0.15 to 0.90 for BepiPred and from 0.50 to 0.90 for AAP12 and BCPred12.

Using the developed pipeline, the default algorithms outputs were parsed and the data of 187,187 in silico predicted epitopes [see Additional file3, Additional file4 and Additional file5] loaded into the MySQL database. In order to evaluate the algorithm performances, predicted epitopes were aligned against the consensus experimentally validated dataset for B cell epitopes. Furthermore, we carried out a combined performance analysis using the best score threshold found for each methodology (Table 1, Figure 4).
Figure 4
Figure 4

ROC (Received Operating Characteristics) curve representing the performance of B cells epitope predictors analyzed (AAP12, BCPred12 and BepiPred), from protozoan proteins database, and their combination.

The AUC performance measure obtained was: 0.53 for BepiPred using a threshold of 0.40; 0.52 for AAP12 using a threshold of 0.80; and 0.62 for BCPred12 using a threshold of 0.90 (Table 1). Regarding the combined performance analysis performed for these algorithms, the following results were found: 0.77 for AAP12 and BCPred12; 0.49 for AAP12 and BepiPred; 0.58 for BCPred12 and BepiPred; and 0.57 for AAP12, BCPred12 and BepiPred.

Subcellular localization of proteins prediction

Regarding prediction of subcellular localization of proteins, three currently available algorithms were selected, WoLF PSORT[27], Sigcleave[28] and TargetP[11]. Using the developed pipeline, the default algorithms outputs were parsed and the data of 538 in silico predictions loaded into the MySQL database. In order to evaluate the algorithms performances, an experimental validated dataset of 180 proteins with described subcellular localization was loaded in addition to in silico predictions. Results show that WoLF PSORT was capable of correctly predicting 27/44 (61.36%) secreted proteins, Sigcleave, 30/44 (68.18%), and TargetP, 32/44 (72.73%), showing that the proportion of correctly predicted binders (sensitivity) was similar between the three algorithms (Table 2). Files containing predictions made by each algorithm are available as Additional files [see for WoLF PSORT, Additional file6; for Sigcleave, Additional file7; for TargetP, Additional file8.
Table 2

Analyzed parameters for subcellular location of proteins


Subcellular location of proteins






61.36% (27/44)

68.18% (30/44)

72.73% (32/44)


93.38% (127/136)

76.47% (104/136)

79.41% (108/136)


74.29% (26/35)

48.39% (30/62)

53.33% (32/60)


88.11% (126/143)

88.14% (104/118)

90% (108/120)


85.39% (152/178)

74.44% (134/180)

77.78% (140/180)

The evaluation of the intersecting portion of predictions made by the tested algorithms showed that, from 40 protozoan proteins with extracellular localization experimentally determined, 19 (~48%) were correctly predicted by all three algorithms (Figure 5).
Figure 5
Figure 5

Venn diagram showing the evaluation of the intersecting portion of predictions made by the tested algorithms for subcellular localization of proteins. The evaluation considered just the proteins experimentally determined as extracellular (n=40).


Despite of being a major public health problem in several countries, the life-threatening diseases caused by protozoan parasites represent a challenge in terms of vaccine development and nowadays there is no efficient vaccine against these parasites.

Epitope prediction by computational methods represents one of the most promising approaches to vaccine development, but there are several drawbacks in the process regarding trypanosomatid genomes. In this context, the lack of sufficiently large datasets of experimentally validated protozoan epitopes represents a serious limitation for validation of parasite in silico epitope prediction.

Several prediction methods were developed, but none of them had protozoan parasites data as training dataset (for some of them, protozoan parasites proteins represent only about 10% of the training dataset[24, 25, 2932]) and, consequently, these results can be biased and should be treated with a grain of salt. The general wisdom is that the performance of epitope prediction methods critically depends on the dataset used for training and also on protein compositional bias. In addition, it is influenced by the evaluation criteria. Regarding epitope prediction in parasite genomes, these drawbacks are noteworthy considering that these organisms have a genome content that reflects proteins with a particular physicochemical profile and that are underrepresented in training datasets.

For this reason, we do not try to rank various prediction methods. Rather, we focus on the key concepts and ideas in the field. Thus, we evaluated algorithm performances focusing on parasites genomes. Comparison between algorithms was made in the basis of AUC (area under a ROC curve) values, which represent the probability that a randomly selected positive instance will score higher than a randomly selected negative instance[33].

Aiming at identifying a good set of tools for protozoan parasites epitope prediction and subcellular localization of proteins, we developed, in this work, a database approach in order to integrate and evaluate the combined performances of some open source currently available algorithms for MHC class I and B-cell epitope prediction, as well as for subcellular localization using protozoan parasites proteins and epitopes experimentally identified.

Concerning the epitope prediction, a database schema was developed and implemented integrating experimental validated data together with the information related to MHC I prediction (NetCTL and NetMHC algorithms) and B-cells prediction (BepiPred, AAP12 and BCPred12 algorithms).

The main source of experimental data was “Immune Epitope Database and Analysis Resource” (IEDB) ([34], that currently represents the main source of linear and conformational epitopes data. Besides, IEDB uses a metric that takes into account the number of references, number of positive assays, and total number of assays for each epitope which is crucial to extract an experimentally validated epitope subset with a high level of confidence for the benchmark.

Regarding MHC I prediction, our AUC results indicate a little difference in the performances related with NetCTL and NetMHC algorithms, 0.66 and 0.60 respectively. If we consider that it is reported that the MHC class I prediction methods have achieved an accuracy that in many cases allows for AUC values in the range 0.95-0.99[22], both algorithms didn′t achieve the expected performance. In fact, this is not the first time that underperformance of prediction algorithms is reported in literature. In a recent study, 167 9mer peptides from Influenza A virus were predicted as potential binders by NetMHC, and just 89 of them (53% of the pool) were confirmed as real binders[35]. Furthermore, the underrepresentation of protozoan proteins in the training datasets in general and the compositional bias certainly have a deep impact on epitope prediction methods and also in the benchmark. In fact, to highlight the different performances of tested algorithms in front of different datasets and exclude the influence of approach undertaken, we evaluated the algorithm performances under the same framework but with the human proteins dataset available for download from NetCTL website[3638]. The results for both NetCTL and NetMHC algorithms were considerably better than the results obtained for protozoan dataset. The AUC value for NetCTL was 0.80 and for NetMHC was 0.77 (Figure 3). In addition, our performance evaluation does not include MHCII prediction since experimental data was insufficiently represented (data not shown). In practice, the prediction of MHC-peptide binding is far from perfect, but this fact does not preclude all the advances made in the last years in the field[21].

Regarding B-cell epitope prediction, our AUC results indicate a better performance for BCPred12 algorithms when compared to AAP12 and BepiPred (Table 1). Again the observed performances were inferior from those currently observed for B-cell epitope predictions[24]. This difference might be explained by same reasons which were just discussed for MHCI prediction. Also for B-cell epitope prediction, this is not the first report in literature of low epitope prediction performance[39].

Lafuente and Reche (2009) believe launching a Critical Assesment of Techniques for Epitope Prediction will benefit the field. Under this program, computational methods will be used for blind de novo prediction of peptides that are immunogenic from query proteins that, for evaluation purposes, has been experimentally screened[21]. Considering that and the results obtained by us, we do believe this approach will be useful to bring advances to epitope prediction area.

Despite of the shortcomings cited above, the combined performance analysis seems to be a promising approach. For B-cell algorithms, when the combined performance analysis was made, the best combination performance was found for AAP12 and BCPred12 that reached an AUC value of 0.77, which is within the expect range reported[24].

Seen in the light of the results obtained, the developed approach calls attention to several points: a) The general prediction models used by currently available algorithms cannot be used with the same performance for different protein subsets (especially true for protozoan parasites); b) The need for studies in which the algorithm performances are evaluated for underrepresented and compositional biased proteins subsets; and c) The combinatorial prediction approach can improve the epitope prediction performance.

Concerning the subcellular localization prediction, the database schema developed also integrated experimental and predicted data for subcellular localization of proteins. Experimental data was obtained from UniProt (, and the in silico predictions made by WoLF PSORT, Sigcleave and TargetP algorithms. The result shows that there is not much difference, in terms of percentage of matches, between the tested algorithms. Nevertheless, the Venn diagram analysis related to true positives (extracellular localization) result shows that the tested algorithms match different proteins in the dataset, and the consensus prediction of the three algorithms would better define a protein located in the extracellular compartment.


Considering the public health importance of the studied organisms and the lack of studies specifically addressing epitope and subcellular localization prediction in these parasites, our results suggest that the algorithm combinatorial approach employed in the developed database-driven epitope prediction methodology is capable of proposing the best set of tools for in silico epitope prediction in protozoan parasite genomes. Several drawbacks exist, but the present work will certainly speed up the process of data mining analysis and prediction of potential candidates for vaccine development.


Databases of experimentally tested epitopes

Two datasets of experimentally tested epitopes were built, one of B-cell epitopes and another of MHC-I epitopes. Parasite proteins experimental datasets where extracted from Immune Epitope Database and Analysis Resource (IEDB)[34, 40, 41]. The following criteria were adopted for epitope selection: a) from protozoan parasites; b) host organism must be mice or human. Selected epitopes were minimal epitopes, experimentally validated as immunogenic [see Additional file9 and Additional file10, for B and T-cell epitopes, respectively] or non-immunogenic [see Additional file11 and Additional file12, for B and T-cell non-immunogenic regions, respectively].

Furthermore, several overlapping epitopes anchored in the same protein region were observed. In order to have a non-redundant set of experimentally validated regions for each protein from dataset, make sense for us to use what we call “the consensus validated region”, which consists to cluster the overlapping epitopes in a unique consensus region called “experimentally validated consensus region”.

Thus, the dataset of B-cell experimental epitopes ended up with 312 proteins and 866 experimentally validated consensus regions including immunogenic and non-immunogenic [see Additional file13 and Additional file14, respectively]; for MHC-I epitopes, 81 proteins and 224 experimentally validated consensus regions including immunogenic and non-immunogenic assignments [see Additional file15 and Additional file16, respectively]. Furthermore, these data were used as input for the formatdb program (BLAST package) which prepares the sequences to be aligned as subject by the BLAST algorithm[42].

Database of proteins with experimentally validated subcellular localization

Proteins with experimentally validated subcellular localization were obtained from UniProt. The search was done with the term “trypanosomatidae”, with the field “subcellular location” set to the confidence “experimental”, which retrieved 180 proteins with subcellular localization described experimentally [see Additional file17 and Additional file18]. This dataset was used to evaluate the three selected algorithms for subcellular localization prediction.

Selection of prediction tools

The prediction algorithms were selected taking into account the possibility of being installed locally, and the reliability of their predictions reported on literature. The predictions of the following algorithms were evaluated: a) for MHCI epitope prediction: NetCTL[22, 32, 43] and NetMHC[23, 31, 44]; b) for B-cell epitope prediction: BepiPred[24] and BCPreds[25, 26, 29], which included two methodologies, AAP12 and BCPred12; c) for protein subcellular localization prediction, WoLF PSORT[27], Sigcleave[28] and TargetP[11].

Score thresholds and allele used

Score thresholds used for CD8+ T cell epitope predictors ranged from 0.50 to 0.90 for NetCTL. We did not set the threshold value for NetMHC because this parameter is not variable in the NetMHC command line mode, so a unique value (0.426) was used for NetMHC. Concerning B cell epitope predictors, the score thresholds ranged from 0.50 to 0.90 for AAP12 and BCPred12 and from 0.15 to 0.90 for BepiPred.

For CD8+ T cell epitopes prediction, the human supertype A2 was the allele model used to scan MHC binding affinity. Other HLA alleles are present in IEDB, but regarding the protozoan proteins they are underrepresented in the non-redundant database used (see previous section). In addition, the supertype HLA-A2 is included in a group which is expressed in 88% of the population, what illustrates the relevance of the supertype used in this work.

Development of parsers and algorithms

Parsers and algorithms were developed in PERL and SQL languages in order to extract the results obtained after running the programs and help to integrate all the results in the relational database.

Construction of relational database

To aggregate all information generated during the development of the project we used MySQL as a Relational Database Management System (RDBMS) ( The use of a database system in this work represents a manner of getting a data receptacle or conceptual repository from which was possible to extract data correlation and results. The MySQL GUI Tools ( were used as a graphical user interface for our MySQL database. The entity-relational model (ERM) was built using MySQL Workbench ( For automatic data parsing and to load information into database, Perl scripts using DBI and BioPerl modules were developed. An overview of implemented workflow is presented in Figure 1.

Analysis of the epitopes results

The developed methodology for result analyses was based on threshold dependent parameters and also on AUC performance analyses. After the identification of the regions of the source proteins which were assigned as consensus experimentally validated regions (immunogenic or non-immunogenic), and with the results of the predictions made by the tested algorithms stored on the constructed relational database, we identified the True Positives (TP) and False Positives (FP) hits. This information was employed in the AUC performance analysis.

In our methodology, we classified the predicted epitopes as TP or FP using the results produced from BLAST algorithm[42]. The following parameters were utilized to decide if a prediction was going to be considered as TP: 1) the local alignment between an epitope prediction (query) and an immunogenic consensus experimentally validated region (subject) had to have minimal query coverage (50% for B cell prediction and 87% for CD8+ T cell). In addition, the coverage cutoff was established based on a minimum size of B cell and CD8+ T cell found in the experimental epitopes database used (IEDB) which are 6 and 8 amino acids respectively. The NetCTL and NetMHC algorithms predict epitopes with 9 amino acids, thus 87% of coverage guarantees the minimum epitope alignment size of 8 amino acids. By the other hand, the AAP12 and BCPred12 algorithms predict epitopes with 12 amino acids, therefore 50% of coverage guarantees the minimum epitope alignment size of 6 amino acids. Regarding the BepiPred algorithm, since it predicts epitopes with variable sizes, only those with at least 6 amino acids were considered in the analysis. Specifically for predictions ranging from 6 to 11 amino acids, the coverage cutoff varied to guarantee a minimal amino acid alignment length of 6 residues. 2) The local alignment between an epitope prediction and a consensus experimentally validated region (immunogenic) had to have 100% of identity. This parameter was used to confirm that a given subject extracted from an alignment exactly matches with the real query. 3) Finally, in order to guarantee subject and query reciprocity the query name and the subject name must be the same. Using the same rational a prediction was considered FP, but the alignment analyses were made using as subject the non-immunogenic consensus experimentally validated region. Predicted epitopes that did not align with the parameters cited just above or if they aligned with both immunogenic and non-immunogenic consensus experimentally validated region were not considered for further analysis.

Algorithms combined predictions

To perform the combined prediction we adopted the following rational: 1) for a given protein, the experimental regions are indexed and so, considering a protein (P) with three experimental validated regions, they would be named P1, P2 and P3; 2) if a given algorithm A predicts an epitope that matches with P2 for instance and another algorithm B predicts an epitope that also matches with P2 they are considered a combined prediction; 3) if a given algorithm A predicts an epitope that matches with P2 and another algorithm B predicts an epitope that matches with P1 or P3 they are not considered as a combined prediction.

Based on the above rules, the combined prediction score was calculated as the mean of the individual normalized scores of the original predictions. The score normalization was done as follows:

NS=(PS-MLS)/((MHS-MLS)/100), where:

NS = normalized score;

PS = prediction score;

MLS = methodology lowest score;

MHS = methodology highest score.

Accuracy evaluation

A non-parametric performance measure was used to avoid the influence of arbitrary thresholds. In order to carry out an accuracy evaluation, we used the area under the ROC curve, or simply AUC, that aggregates the model’s behavior for all possible decision thresholds. The nonparametric estimate of the AUC[45] was calculated through an implemented GNU R package called ROCR[33].

Analysis of the subcellular localization results

In order to analyze the subcellular localization prediction results, we determined the True Positives (TP), True Negatives (TN), False Positives (FP) and False Negatives (FN). This information was incorporated into a confusing error matrix that allowed the determination of parameters: sensitivity (Sn), specificity (Sp), positive predictive value (PPV), negative predictive value (NPV) and accuracy (Table 3).
Table 3

Parameters used in the analysis of the results


Brief description


Sensitivity (Sn)

The proportion of correctly predicted binders

(a/(a + c))*100

Specificity (Sp)

The proportion of correctly predicted non-binders

(d/(b + d))*100

Positive Predictive Value (PPV)

The probability that a predicted binder will actually be a binder

(a/(a + b))*100

Negative Predictive Value (NPV)

The probability that a predicted non-binder will actually be a non-binder

(d/(c + d))*100


The proportion of correctly predicted peptides (both binders and non-binders)

((a + d)/(a+b+c+d)*100

a = True positive observations.

b = False positive observations.

c = False negative observations.

d = True negative observations.




We thank for the following institutions and agencies for their past and current support for our research: FAPEMIG (Fundação de Amparo à Pesquisa do Estado de Minas Gerais; CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico); Instituto René Rachou (IRR/FIOCRUZ Minas); Universidade Federal de Ouro Preto (UFOP); Programa de Pós-graduação em Ciências Farmacêuticas (CiPharma) Pontifícia Universidade Católica (PUC-MG) and Centro Universitário UNA. Grants FAPEMIG (PRONEX 503/07 and PPP APQ-04554-10), CNPq (GENOPROT 560943/2010-5 and Universal 478100/2011-6) and CAPES (PNPD 2009). JCR is also supported by the following grants: CNPq 476898/2008-0 and 476539/2010-2; FAPEMIG APQ-02382-10 and APQ-01835-10. Fellowships were provided by CNPq to ABR, RCO, RT and PCR, by CAPES to DMR and by FAPEMIG to ICAB. We would like to thank Patrícia Cássia Ruy and Raul Torrieri for the comments given at the beginning of this work.

Authors’ Affiliations

Programa de Pós-graduação em Ciências Farmacêuticas (CiPharma), Laboratório de Pesquisas Clínicas, Escola de Farmácia, Universidade Federal de Ouro Preto, Campus Morro do Cruzeiro, Ouro Preto, MG, 35400-000, Brazil
Laboratório de Imunologia Celular e Molecular, Instituto René Rachou, Av. Augusto de Lima, 1715, Barro Preto, Belo Horizonte, MG, 30190-002, Brazil
Laboratório de Imunopatologia, Núcleo de Pesquisas em Ciências Biológicas, Universidade Federal de Ouro Preto, Campus Morro do Cruzeiro, ICEB II, Ouro Preto, MG, 35400-000, Brazil
Laboratório de Parasitologia Celular e Molecular, Instituto René Rachou, Av. Augusto de Lima, 1715, Barro Preto, Belo Horizonte, MG, 30190-002, Brazil
Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, Pampulha, 6627, 31270-901 Belo Horizonte, MG, Brazil
Pontifícia Universidade Católica, R. Rio Comprido, 4580, Monte Castelo, Contagem, MG, 32285-040, Brazil
Centro Universitário UNA, Instituto de Ciências Biológicas e da Saúde (ICBS), R. Guajajaras, 175, Centro, Belo Horizonte, MG, 30180-100, Brazil


  1. Bambini S, Rappuoli R: The use of genomics in microbial vaccine development. Drug DiscovToday 2009, 14(5–6):252–260.Google Scholar
  2. Rinaudo CD, Telford JL, Rappuoli R, Seib KL: Vaccinology in the genome era. JClinInvest 2009, 119(9):2515–2525.Google Scholar
  3. Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, Comanducci M, Jennings GT, Baldi L, Bartolini E, Capecchi B, et al.: Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000, 287(5459):1816–1820. 10.1126/science.287.5459.1816View ArticlePubMedGoogle Scholar
  4. Andre FE: Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine 1990, 8(Suppl):S74-S78.View ArticlePubMedGoogle Scholar
  5. Korber B, LaBute M, Yusim K: Immunoinformatics comes of age. PLoSComputBiol 2006, 2(6):e71.Google Scholar
  6. Borja-Cabrera GP, Cruz Mendes A, Paraguai De Souza E, Hashimoto Okada LY, De ATFA, Kawasaki JK, Costa AC, Reis AB, Genaro O, Batista LM, et al.: Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine. Vaccine 2004, 22(17–18):2234–2243.View ArticlePubMedGoogle Scholar
  7. Emanuelsson O, von Heijne G: Prediction of organellar targeting signals. BiochimBiophysActa 2001, 1541(1–2):114–119.Google Scholar
  8. Feng ZP: An overview on predicting the subcellular location of a protein. In SilicoBiol 2002, 2(3):291–303.Google Scholar
  9. Bannai H, Tamada Y, Maruyama O, Nakai K, Miyano S: Extensive feature detection of N-terminal protein sorting signals. Bioinformatics 2002, 18(2):298–305. 10.1093/bioinformatics/18.2.298View ArticlePubMedGoogle Scholar
  10. Cedano J, Aloy P, Perez-Pons JA, Querol E: Relation between amino acid composition and cellular location of proteins. JMolBiol 1997, 266(3):594–600.Google Scholar
  11. Emanuelsson O, Nielsen H, Brunak S, von Heijne G: Predicting subcellular localization of proteins based on their N-terminal amino acid sequence. JMolBiol 2000, 300(4):1005–1016.Google Scholar
  12. Hua S, Sun Z: Support vector machine approach for protein subcellular localization prediction. Bioinformatics 2001, 17(8):721–728. 10.1093/bioinformatics/17.8.721View ArticlePubMedGoogle Scholar
  13. Baldi P, Atiya AF: How delays affect neural dynamics and learning. IEEE TransNeural Netw 1994, 5(4):612–621. 10.1109/72.298231View ArticleGoogle Scholar
  14. Hughey R, Krogh A: Hidden Markov models for sequence analysis: extension and analysis of the basic method. ComputApplBiosci 1996, 12(2):95–107.Google Scholar
  15. Vapnik V, Vashist A: A new learning paradigm: learning using privileged information. Neural Netw 2009, 22(5–6):544–557.View ArticlePubMedGoogle Scholar
  16. Lundegaard C, Lund O, Kesmir C, Brunak S, Nielsen M: Modeling the adaptive immune system: predictions and simulations. Bioinformatics 2007, 23(24):3265–3275. 10.1093/bioinformatics/btm471View ArticlePubMedGoogle Scholar
  17. Mamitsuka H: Predicting peptides that bind to MHC molecules using supervised learning of hidden Markov models. Proteins 1998, 33(4):460–474. 10.1002/(SICI)1097-0134(19981201)33:4<460::AID-PROT2>3.0.CO;2-MView ArticlePubMedGoogle Scholar
  18. Shekhar S, Chawla S: Spatial databases: a tour. Upper Saddle River: Prentice-Hall; 2002.Google Scholar
  19. Elmasri RA, Navathe SB: Fundamentals of databases systems. New York: Addision-Wesley Pubishing; 2000.Google Scholar
  20. Markowitz VM: Biological data management in a dataspace framework: biological data management and technology center. Philadelphia: Lawrence Berkeley National Laboratory; 2006.Google Scholar
  21. Ostell JM, Wheelan SJ, Kans JA: The NCBI Data Model. In: Bioinformatics: A Practical Guide to the Analysis of Genes and Proteins. 2nd edition. Edited by: Baxevanis AD, Ouellette BFF. New York: John Wiley & Sons Publishing; 2001:19–44.Google Scholar
  22. Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M: Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinforma 2007, 8: 424. 10.1186/1471-2105-8-424View ArticleGoogle Scholar
  23. Nielsen M, Lundegaard C, Worning P, Hvid CS, Lamberth K, Buus S, Brunak S, Lund O: Improved prediction of MHC class I and class II epitopes using a novel gibbs sampling approach. Bioinformatics 2004, 20(9):1388–1397. 10.1093/bioinformatics/bth100View ArticlePubMedGoogle Scholar
  24. Larsen JE, Lund O, Nielsen M: Improved method for predicting linear B-cell epitopes. ImmunomeRes 2006, 2: 2.View ArticleGoogle Scholar
  25. El Manzalawy Y, Dobbs D, Honavar V: Predicting linear B-cell epitopes using string kernels. JMolRecognit 2008, 21(4):243–255.Google Scholar
  26. Chen J, Liu H, Yang J, Chou KC: Prediction of linear B-cell epitopes using amino acid pair antigenicity scale. AminoAcids 2007, 33(3):423–428.Google Scholar
  27. Horton P, Park KJ, Obayashi T, Fujita N, Harada H, Adams-Collier CJ, Nakai K: WoLF PSORT: protein localization predictor. Nucleic Acids Res 2007, 35(Web Server issue):W585-W587.PubMed CentralView ArticlePubMedGoogle Scholar
  28. von Heijne G: A new method for predicting signal sequence cleavage sites. Nucleic Acids Res 1986, 14(11):4683–4690. 10.1093/nar/14.11.4683PubMed CentralView ArticlePubMedGoogle Scholar
  29. El Manzalawy Y, Dobbs D, Honavar V: Predicting flexible length linear B-cell epitopes. ComputSystBioinformatics Conf 2008, 7: 121–132.Google Scholar
  30. Nielsen M, Lund O: NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinforma 2009, 10: 296. 10.1186/1471-2105-10-296View ArticleGoogle Scholar
  31. Nielsen M, Lundegaard C, Worning P, Lauemoller SL, Lamberth K, Buus S, Brunak S, Lund O: Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 2003, 12(5):1007–1017. 10.1110/ps.0239403PubMed CentralView ArticlePubMedGoogle Scholar
  32. Peters B, Bulik S, Tampe R, Van Endert PM, Holzhutter HG: Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. JImmunol 2003, 171(4):1741–1749.View ArticleGoogle Scholar
  33. Wu S, Flach P ROCML workshop at ICML. In A scored AUC metric for classifier evaluation and selection. Bonn: Citeseer; 2005.Google Scholar
  34. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R, Sette A, Peters B: The immune epitope database 2.0. Nucleic Acids Res 2009, 38(Database issue):D854-D862.PubMed CentralPubMedGoogle Scholar
  35. Wang M, Lamberth K, Harndahl M, Roder G, Stryhn A, Larsen MV, Nielsen M, Lundegaard C, Tang ST, Dziegiel MH, et al.: CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening. Vaccine 2007, 25(15):2823–2831. 10.1016/j.vaccine.2006.12.038View ArticlePubMedGoogle Scholar
  36. NetCTL[]
  37. NetCTL SYFPEITHI dataset[]
  38. Larsen MV, Lundegaard C, Lamberth K, Buus S, Brunak S, Lund O, Nielsen M: An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur J Immunol 2005, 35(8):2295–2303. 10.1002/eji.200425811View ArticlePubMedGoogle Scholar
  39. Sebatjane S, Pretorius A, Liebenberg J, Steyn H, Van Kleef M: In vitro and in vivo evaluation of five low molecular weight proteins of ehrlichia ruminantium as potential vaccine components. Vet Immunol Immunopathol 2010, 137(3–4):217–225.View ArticlePubMedGoogle Scholar
  40. Vita R, Peters B, Sette A: The curation guidelines of the immune epitope database and analysis resource. Cytometry A 2008, 73(11):1066–1070.PubMed CentralView ArticlePubMedGoogle Scholar
  41. Vita R, Vaughan K, Zarebski L, Salimi N, Fleri W, Grey H, Sathiamurthy M, Mokili J, Bui HH, Bourne PE, et al.: Curation of complex, context-dependent immunological data. BMC Bioinforma 2006, 7: 341. 10.1186/1471-2105-7-341View ArticleGoogle Scholar
  42. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. JMolBiol 1990, 215(3):403–410.Google Scholar
  43. Nielsen M, Lundegaard C, Lund O, Kesmir C: The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 2005, 57(1–2):33–41.View ArticlePubMedGoogle Scholar
  44. Buus S, Lauemoller SL, Worning P, Kesmir C, Frimurer T, Corbet S, Fomsgaard A, Hilden J, Holm A, Brunak S: Sensitive quantitative predictions of peptide-MHC binding by a ‘Query by Committee’ artificial neural network approach. Tissue Antigens 2003, 62(5):378–384. 10.1034/j.1399-0039.2003.00112.xView ArticlePubMedGoogle Scholar
  45. Sing T, Sander O, Beerenwinkel N, Lengauer T: ROCR: visualizing classifier performance in R. Bioinformatics 2005, 21(20):3940–3941. 10.1093/bioinformatics/bti623View ArticlePubMedGoogle Scholar


© Resende et al.; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.